The final seven clinical trial sessions of the ATS International Conference, at which data that may have immediate or near-immediate implications for attendees in their practices, will be presented from noon to 1 p.m. Wednesday.

Among the sessions to be held tomorrow is “Findings from Inner-City Anti-IgE Therapy for Asthma (ICATA),” which is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). The session will be co-chaired by Peter J. Gergen, M.D., M.P.H., medical officer of the NIAID’s
Division of Allergy, Immunology and Transplantation, and Alkis Togias, M.D., section chief of the NIAID’s Asthma and Inflammation Section.

“The ICATA evaluated the impact of adding omalizumab to guidelines base-therapy in moderate to severe persistent asthmatics,” Dr. Gergen said. “There are some very interesting findings dealing with allergen sensitization/exposure and the fall increase in asthma exacerbations will be presented.”

The following clinical trial sessions will also provide conference attendees with the latest information about diagnosing and treating respiratory, critical care and sleep disorders.

L15: “Findings from Inner-City ANTI-IGE Therapy for Asthma (ICATA)”

L16: “Using NASA’s Satellite Remote Sensors for the Study of the Environment and Diseases”

L17: “Pulmonary Update from the U.S. Food and Drug Administration”

L18: “Update on NHLBI Acute Respiratory Distress Network (ARDSnet): Clinical Trials and Ancillary Studies”

L19: “Candidate Gene Association Resource (CARe): Genetic Associations for Lung, Sleep and Obesity Phenotypes”

L20: “The National Heart, Lung, and Blood Institute Lung HIV Study: A New Model for Collaborative Clinical and Translational Research”

L21: “Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III)”

Also presented on Wednesday will be a symposium, sponsored by the National Heart, Lung, and Blood Institute (NHLBI), “Candidate Gene Association Resource (CARe): Genetic Associations for Lung, Sleep and Obesity Phenotypes.”

Michael Twery, Ph.D, director and branch chief of the NHLBI’s National Center on Sleep Disorders Research in Bethesda, will serve as session co-chair.